AG˹ٷ

STOCK TITAN

[8-K] Soligenix, Inc. Reports Material Event

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

On June 20, 2025, Soligenix, Inc. (Nasdaq: SNGX) filed an 8-K summarizing the results of its 2025 Annual Meeting of Stockholders.

  • 2025 Equity Incentive Plan: Approved with 215,332 votes For, 91,937 Against and 57,226 Abstain (1,168,832 broker non-votes). Forms of stock option and restricted stock agreements were filed as Exhibits 10.2 and 10.3.
  • Board Elections: All five incumbent directors were re-elected. Support ranged from 329,054 to 332,492 votes For; broker non-votes totaled 1,168,832.
  • Say-on-Pay: Executive compensation received advisory approval (303,633 For; 53,830 Against; 7,032 Abstain).
  • Auditor Ratification: Cherry Bekaert, LLP was ratified for FY 2025 (1,476,465 For; 54,474 Against; 2,388 Abstain).
  • Adjournment Authority: Approved with 1,227,450 For; 295,013 Against; 10,864 Abstain.

No operational updates, financial results or major strategic transactions were disclosed; the filing is primarily governance-oriented and does not materially affect near-term fundamentals.

Il 20 giugno 2025, Soligenix, Inc. (Nasdaq: SNGX) ha presentato un 8-K riepilogativo dei risultati della sua Assemblea Annuale degli Azionisti del 2025.

  • Piano di Incentivi Azionari 2025: Approvato con 215.332 voti a favore, 91.937 contrari e 57.226 astenuti (1.168.832 voti di intermediazione non espressi). Le tipologie di accordi per opzioni azionarie e azioni vincolate sono state depositate come Allegati 10.2 e 10.3.
  • Elezioni del Consiglio: Tutti e cinque i direttori in carica sono stati rieletti. Il sostegno è variato da 329.054 a 332.492 voti a favore; i voti di intermediazione non espressi sono stati 1.168.832.
  • Say-on-Pay: La remunerazione degli executive ha ricevuto un’approvazione consultiva (303.633 a favore; 53.830 contrari; 7.032 astenuti).
  • Ratifica del Revisore: Cherry Bekaert, LLP è stata ratificata per l’esercizio 2025 (1.476.465 a favore; 54.474 contrari; 2.388 astenuti).
  • Autorità di Rinviare l’Assemblea: Approvata con 1.227.450 voti a favore; 295.013 contrari; 10.864 astenuti.

Non sono stati comunicati aggiornamenti operativi, risultati finanziari o transazioni strategiche rilevanti; il documento ha principalmente carattere di governance e non incide in modo significativo sui fondamentali a breve termine.

El 20 de junio de 2025, Soligenix, Inc. (Nasdaq: SNGX) presentó un 8-K que resume los resultados de su Junta Anual de Accionistas de 2025.

  • Plan de Incentivos de Acciones 2025: Aprobado con 215,332 votos a favor, 91,937 en contra y 57,226 abstenciones (1,168,832 votos de corredores no emitidos). Se presentaron los modelos de acuerdos para opciones sobre acciones y acciones restringidas como Anexos 10.2 y 10.3.
  • Elecciones de la Junta: Los cinco directores incumbentes fueron reelectos. El apoyo varió entre 329,054 y 332,492 votos a favor; los votos de corredores no emitidos totalizaron 1,168,832.
  • Say-on-Pay: La compensación ejecutiva recibió aprobación consultiva (303,633 a favor; 53,830 en contra; 7,032 abstenciones).
  • Ratificación del Auditor: Cherry Bekaert, LLP fue ratificado para el año fiscal 2025 (1,476,465 a favor; 54,474 en contra; 2,388 abstenciones).
  • Autoridad para Aplazar la Junta: Aprobada con 1,227,450 votos a favor; 295,013 en contra; 10,864 abstenciones.

No se divulgaron actualizaciones operativas, resultados financieros ni transacciones estratégicas importantes; la presentación es principalmente de carácter de gobernanza y no afecta materialmente los fundamentos a corto plazo.

2025� 6� 20�, Soligenix, Inc. (나스�: SNGX)은 2025� 주주총회 결과� 요약� 8-K 보고서를 제출했습니다.

  • 2025� 주식 인센티브 계획: 찬성 215,332�, 반대 91,937�, 기권 57,226표로 승인되었으며, 중개� 미투표는 1,168,832표였습니�. 주식 옵션 � 제한 주식 계약� 양식은 부속서 10.2 � 10.3으로 제출되었습니�.
  • 이사� 선거: 현직 이사 5� 전원� 재선되었습니�. 찬성표는 329,054표에� 332,492� 사이였으며, 중개� 미투표는 1,168,832표였습니�.
  • 임원 보수 승인(Say-on-Pay): 임원 보수� 대� 자문 승인(찬성 303,633�; 반대 53,830�; 기권 7,032�)� 받았습니�.
  • 감사� 승인: Cherry Bekaert, LLP가 2025 회계연도 감사인으� 승인되었습니�(찬성 1,476,465�; 반대 54,474�; 기권 2,388�).
  • 총회 연기 권한: 찬성 1,227,450�; 반대 295,013�; 기권 10,864표로 승인되었습니�.

운영 업데이트, 재무 결과 또는 주요 전략� 거래� 공개되지 않았으며, 이번 제출은 주로 거버넌스 관� 내용으로 단기 펀더멘털에 중대� 영향� 미치지 않습니다.

Le 20 juin 2025, Soligenix, Inc. (Nasdaq : SNGX) a déposé un 8-K résumant les résultats de son Assemblée Générale Annuelle des Actionnaires 2025.

  • Plan d’Incitation en Actions 2025 : Approuvé avec 215 332 votes pour, 91 937 contre et 57 226 abstentions (1 168 832 votes de courtiers non exprimés). Les modèles de contrats d’options d’achat d’actions et d’actions restreintes ont été déposés en tant qu’Exhibits 10.2 et 10.3.
  • Élections du Conseil d’Administration : Les cinq administrateurs en poste ont tous été réélus. Le soutien variait de 329 054 à 332 492 votes pour ; les votes de courtiers non exprimés s’élevaient à 1 168 832.
  • Say-on-Pay : La rémunération des dirigeants a reçu une approbation consultative (303 633 pour ; 53 830 contre ; 7 032 abstentions).
  • Ratification de l’Auditeur : Cherry Bekaert, LLP a été ratifié pour l’exercice 2025 (1 476 465 pour ; 54 474 contre ; 2 388 abstentions).
  • Autorisation de Report : Approuvée avec 1 227 450 votes pour ; 295 013 contre ; 10 864 abstentions.

Aucune mise à jour opérationnelle, résultat financier ou transaction stratégique majeure n’a été divulguée ; le dépôt est principalement axé sur la gouvernance et n’affecte pas de manière significative les fondamentaux à court terme.

Am 20. Juni 2025 reichte Soligenix, Inc. (Nasdaq: SNGX) ein 8-K-Formular ein, das die Ergebnisse der Hauptversammlung 2025 zusammenfasst.

  • Aktienanreizplan 2025: Genehmigt mit 215.332 Stimmen dafür, 91.937 dagegen und 57.226 Enthaltungen (1.168.832 Broker-Non-Votes). Formen von Aktienoptions- und Restricted-Stock-Vereinbarungen wurden als Anlagen 10.2 und 10.3 eingereicht.
  • Vorstands-Wahlen: Alle fünf amtierenden Direktoren wurden wiedergewählt. Die Unterstützung reichte von 329.054 bis 332.492 Stimmen dafür; Broker-Non-Votes beliefen sich auf 1.168.832.
  • Say-on-Pay: Die Vergütung der Führungskräfte erhielt eine beratende Zustimmung (303.633 dafür; 53.830 dagegen; 7.032 Enthaltungen).
  • ʰüڱäپܲԲ: Cherry Bekaert, LLP wurde für das Geschäftsjahr 2025 bestätigt (1.476.465 dafür; 54.474 dagegen; 2.388 Enthaltungen).
  • Vertagungsbefugnis: Genehmigt mit 1.227.450 Stimmen dafür; 295.013 dagegen; 10.864 Enthaltungen.

Es wurden keine operativen Updates, Finanzzahlen oder bedeutende strategische Transaktionen bekanntgegeben; die Einreichung ist hauptsächlich governance-orientiert und beeinflusst die kurzfristigen Fundamentaldaten nicht wesentlich.

Positive
  • Continuity in leadership and oversight: All incumbent directors were re-elected and Cherry Bekaert, LLP was ratified as auditor, preserving governance stability.
Negative
  • Potential shareholder dilution: Approval of the 2025 Equity Incentive Plan increases the authorized share pool for equity awards.

Insights

TL;DR: Routine AGM approvals; neutral impact, minor dilution risk from new equity plan.

The 8-K covers standard governance items. Re-election of directors and auditor ratification sustain leadership continuity and reporting stability—baseline expectations for investors. The newly approved 2025 Equity Incentive Plan refreshes the share-based compensation pool, aligning management incentives but creating potential future dilution; roughly 30% of votes (Against + Abstain + broker non-votes) did not support it, signaling modest shareholder concern. With no financial metrics or strategic shifts announced, the disclosure is unlikely to drive immediate valuation changes. Overall impact is neutral.

Il 20 giugno 2025, Soligenix, Inc. (Nasdaq: SNGX) ha presentato un 8-K riepilogativo dei risultati della sua Assemblea Annuale degli Azionisti del 2025.

  • Piano di Incentivi Azionari 2025: Approvato con 215.332 voti a favore, 91.937 contrari e 57.226 astenuti (1.168.832 voti di intermediazione non espressi). Le tipologie di accordi per opzioni azionarie e azioni vincolate sono state depositate come Allegati 10.2 e 10.3.
  • Elezioni del Consiglio: Tutti e cinque i direttori in carica sono stati rieletti. Il sostegno è variato da 329.054 a 332.492 voti a favore; i voti di intermediazione non espressi sono stati 1.168.832.
  • Say-on-Pay: La remunerazione degli executive ha ricevuto un’approvazione consultiva (303.633 a favore; 53.830 contrari; 7.032 astenuti).
  • Ratifica del Revisore: Cherry Bekaert, LLP è stata ratificata per l’esercizio 2025 (1.476.465 a favore; 54.474 contrari; 2.388 astenuti).
  • Autorità di Rinviare l’Assemblea: Approvata con 1.227.450 voti a favore; 295.013 contrari; 10.864 astenuti.

Non sono stati comunicati aggiornamenti operativi, risultati finanziari o transazioni strategiche rilevanti; il documento ha principalmente carattere di governance e non incide in modo significativo sui fondamentali a breve termine.

El 20 de junio de 2025, Soligenix, Inc. (Nasdaq: SNGX) presentó un 8-K que resume los resultados de su Junta Anual de Accionistas de 2025.

  • Plan de Incentivos de Acciones 2025: Aprobado con 215,332 votos a favor, 91,937 en contra y 57,226 abstenciones (1,168,832 votos de corredores no emitidos). Se presentaron los modelos de acuerdos para opciones sobre acciones y acciones restringidas como Anexos 10.2 y 10.3.
  • Elecciones de la Junta: Los cinco directores incumbentes fueron reelectos. El apoyo varió entre 329,054 y 332,492 votos a favor; los votos de corredores no emitidos totalizaron 1,168,832.
  • Say-on-Pay: La compensación ejecutiva recibió aprobación consultiva (303,633 a favor; 53,830 en contra; 7,032 abstenciones).
  • Ratificación del Auditor: Cherry Bekaert, LLP fue ratificado para el año fiscal 2025 (1,476,465 a favor; 54,474 en contra; 2,388 abstenciones).
  • Autoridad para Aplazar la Junta: Aprobada con 1,227,450 votos a favor; 295,013 en contra; 10,864 abstenciones.

No se divulgaron actualizaciones operativas, resultados financieros ni transacciones estratégicas importantes; la presentación es principalmente de carácter de gobernanza y no afecta materialmente los fundamentos a corto plazo.

2025� 6� 20�, Soligenix, Inc. (나스�: SNGX)은 2025� 주주총회 결과� 요약� 8-K 보고서를 제출했습니다.

  • 2025� 주식 인센티브 계획: 찬성 215,332�, 반대 91,937�, 기권 57,226표로 승인되었으며, 중개� 미투표는 1,168,832표였습니�. 주식 옵션 � 제한 주식 계약� 양식은 부속서 10.2 � 10.3으로 제출되었습니�.
  • 이사� 선거: 현직 이사 5� 전원� 재선되었습니�. 찬성표는 329,054표에� 332,492� 사이였으며, 중개� 미투표는 1,168,832표였습니�.
  • 임원 보수 승인(Say-on-Pay): 임원 보수� 대� 자문 승인(찬성 303,633�; 반대 53,830�; 기권 7,032�)� 받았습니�.
  • 감사� 승인: Cherry Bekaert, LLP가 2025 회계연도 감사인으� 승인되었습니�(찬성 1,476,465�; 반대 54,474�; 기권 2,388�).
  • 총회 연기 권한: 찬성 1,227,450�; 반대 295,013�; 기권 10,864표로 승인되었습니�.

운영 업데이트, 재무 결과 또는 주요 전략� 거래� 공개되지 않았으며, 이번 제출은 주로 거버넌스 관� 내용으로 단기 펀더멘털에 중대� 영향� 미치지 않습니다.

Le 20 juin 2025, Soligenix, Inc. (Nasdaq : SNGX) a déposé un 8-K résumant les résultats de son Assemblée Générale Annuelle des Actionnaires 2025.

  • Plan d’Incitation en Actions 2025 : Approuvé avec 215 332 votes pour, 91 937 contre et 57 226 abstentions (1 168 832 votes de courtiers non exprimés). Les modèles de contrats d’options d’achat d’actions et d’actions restreintes ont été déposés en tant qu’Exhibits 10.2 et 10.3.
  • Élections du Conseil d’Administration : Les cinq administrateurs en poste ont tous été réélus. Le soutien variait de 329 054 à 332 492 votes pour ; les votes de courtiers non exprimés s’élevaient à 1 168 832.
  • Say-on-Pay : La rémunération des dirigeants a reçu une approbation consultative (303 633 pour ; 53 830 contre ; 7 032 abstentions).
  • Ratification de l’Auditeur : Cherry Bekaert, LLP a été ratifié pour l’exercice 2025 (1 476 465 pour ; 54 474 contre ; 2 388 abstentions).
  • Autorisation de Report : Approuvée avec 1 227 450 votes pour ; 295 013 contre ; 10 864 abstentions.

Aucune mise à jour opérationnelle, résultat financier ou transaction stratégique majeure n’a été divulguée ; le dépôt est principalement axé sur la gouvernance et n’affecte pas de manière significative les fondamentaux à court terme.

Am 20. Juni 2025 reichte Soligenix, Inc. (Nasdaq: SNGX) ein 8-K-Formular ein, das die Ergebnisse der Hauptversammlung 2025 zusammenfasst.

  • Aktienanreizplan 2025: Genehmigt mit 215.332 Stimmen dafür, 91.937 dagegen und 57.226 Enthaltungen (1.168.832 Broker-Non-Votes). Formen von Aktienoptions- und Restricted-Stock-Vereinbarungen wurden als Anlagen 10.2 und 10.3 eingereicht.
  • Vorstands-Wahlen: Alle fünf amtierenden Direktoren wurden wiedergewählt. Die Unterstützung reichte von 329.054 bis 332.492 Stimmen dafür; Broker-Non-Votes beliefen sich auf 1.168.832.
  • Say-on-Pay: Die Vergütung der Führungskräfte erhielt eine beratende Zustimmung (303.633 dafür; 53.830 dagegen; 7.032 Enthaltungen).
  • ʰüڱäپܲԲ: Cherry Bekaert, LLP wurde für das Geschäftsjahr 2025 bestätigt (1.476.465 dafür; 54.474 dagegen; 2.388 Enthaltungen).
  • Vertagungsbefugnis: Genehmigt mit 1.227.450 Stimmen dafür; 295.013 dagegen; 10.864 Enthaltungen.

Es wurden keine operativen Updates, Finanzzahlen oder bedeutende strategische Transaktionen bekanntgegeben; die Einreichung ist hauptsächlich governance-orientiert und beeinflusst die kurzfristigen Fundamentaldaten nicht wesentlich.

0000812796falseDE00008127962025-06-202025-06-20

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

 

Date of Report (Date of Earliest Event Reported):  June 20, 2025

 

Commission File No. 001-14778

 

Soligenix, Inc.

(Exact name of small business issuer as specified in its charter)

 

DELAWARE

 

41-1505029

(State or other jurisdiction of
incorporation or organization)

 

(I.R.S. Employer
Identification Number)

 

 

 

29 Emmons Drive,

Suite B-10

Princeton, NJ

 

08540

(Address of principal executive offices)

 

(Zip Code)

(609) 538-8200

(Issuer’s telephone number, including area code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading Symbol(s)

 

Name of each exchange on which registered

Common Stock, par value $.001 per share

 

SNGX

 

The Nasdaq Capital Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

w

Item 5.02.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On June 20, 2025, Soligenix, Inc. (the “Company”) held its 2025 annual meeting of stockholders (the “Annual Meeting”), at which the stockholders approved the 2025 Equity Incentive Plan (the “2025 Plan”). A summary of the 2025 Plan was included as part of Proposal 2 in the Company's proxy statement (the “Proxy Statement”) filed with the Securities and Exchange Commission on May 5, 2025. The summary of the 2025 Plan contained in the Proxy Statement is qualified by and subject to the full text of the 2025 Plan, which is filed as Exhibit 10.1 to this report. The forms of stock option agreement and restricted stock purchase agreement under the 2025 Plan are filed as Exhibits 10.2 and 10.3, respectively, to this report.

Item 5.07. Submission of Matters to a Vote of Security Holders.

 

On June 20, 2025, at the Annual Meeting, the following items were voted upon:

 

Proposal 1 – Election of Directors:

 

The following five nominees were elected as directors to serve until the 2025 Annual Meeting of Stockholders by votes as follows:

 

Name

 

For

 

 

Withheld

 

Christopher J. Schaber, PhD

 

 

330,950

33,545

 

Gregg A. Lapointe, CPA, MBA

332,492

32,003

Diane L. Parks, MBA

 

 

331,054

33,441

 

Robert J. Rubin, MD

 

 

331,046

33,449

 

Jerome B. Zeldis, MD, PhD

 

 

329,054

35,441

 

There were 1,168,832 broker non-votes in the election of directors.

Proposal 2 – 2025 Equity Incentive Plan:

 

The proposal to approve the 2025 Plan was approved, and the votes were as follows:

 

For

 

Against

 

Abstain

215,332

 

91,937

 

57,226

There were 1,168,832 broker non-votes on this proposal.

Proposal 3 – Non-Binding Advisory Vote on Executive Compensation:

 

The proposal to approve, by a non-binding advisory vote, the compensation of the Company’s named executive officers as disclosed in the Company’s 2025 proxy statement was approved, and the votes were as follows:

 

03,633

For

 

Against

 

Abstain

303,633

 

53,830

 

7,032

 

2

There were 1,168,832 broker non-votes on this proposal.

Proposal 4 – Ratification of Auditors:

The proposal to ratify the appointment of Cherry Bekaert, LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2025 was approved by votes as follows:

 

For

 

Against

 

Abstain

1,476,465

 

54,474

 

2,388

There were no broker non-votes on this proposal.

 

Proposal 5 – Adjournment Proposal:

 

The proposal to approve an adjournment of the Annual Meeting, in whole or in part as to any particular proposal(s), to a later date or dates, if necessary, to permit further solicitation of proxies in the event there are not sufficient shares voted to constitute a quorum or votes in favor of a particular proposal for approval, was approved, and the votes were as follows:

 

For

 

Against

 

Abstain

1,227,450

 

295,013

 

10,864

There were no broker non-votes on this proposal.

Item 9.01. Financial Statements and Exhibits.

(d)     Exhibits.

Exhibit No.

    

Description

10.1

Soligenix, Inc. 2025 Equity Incentive Plan

10.2

Form of Stock Option Agreement for 2025 Plan

10.3

Form of Restricted Stock Agreement for 2025 Plan

104

Cover Page Interactive Data File (embedded within the Inline XBRL document)

3

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Soligenix, Inc. 

June 20, 2025

By:

/s/ Christopher J. Schaber 

 

 

Christopher J. Schaber, Ph.D.

President and Chief Executive Officer

(Principal Executive Officer)

4

FAQ

Which proposals were approved at Soligenix's 2025 Annual Meeting?

Shareholders approved the 2025 Equity Incentive Plan, re-elected all five directors, ratified Cherry Bekaert, LLP as auditor, passed the say-on-pay advisory vote and granted adjournment authority.

How did shareholders vote on the Soligenix 2025 Equity Incentive Plan?

215,332 votes For, 91,937 Against, 57,226 Abstain, with 1,168,832 broker non-votes.

Did Soligenix (SNGX) shareholders approve executive compensation?

Yes. The non-binding say-on-pay proposal passed with 303,633 For, 53,830 Against and 7,032 Abstain votes.

Which audit firm will serve Soligenix for fiscal 2025?

Shareholders ratified Cherry Bekaert, LLP with 1,476,465 votes For.

Were there any changes to Soligenix’s board composition?

No. All incumbent directors—including Christopher J. Schaber and Gregg A. Lapointe—were re-elected to serve until the 2026 AGM.
Soligenix Inc

NASDAQ:SNGX

SNGX Rankings

SNGX Latest News

SNGX Latest SEC Filings

SNGX Stock Data

4.08M
3.26M
0.03%
1.22%
4.01%
Biotechnology
Pharmaceutical Preparations
United States
PRINCETON